Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients' Health Status.
Ryo NakamaruNobuhiro IkemuraTakehiro KimuraYoshinori KatsumataCharles F SherrodHiroshi MiyamaYasuyuki ShiraishiHideaki KankiKoji NegishiIkuko UedaKeiichi FukudaSeiji TakatsukiShun KohsakaPublished in: Journal of clinical medicine (2023)
OAC discontinuation was common among AF patients with significant stroke risk but varied depending on the chosen treatment strategy. This study also found no significant association between OAC discontinuation and patients' health status.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- patient reported outcomes
- acute coronary syndrome
- percutaneous coronary intervention
- brain injury
- blood brain barrier
- mitral valve
- replacement therapy